IVF During Perimenopause: Realistic Options & Honest Expectations

Perimenopause — the transitional period before menopause, typically beginning in the mid-40s but sometimes earlier — doesn't mean fertility is over. But it does mean the window is narrowing rapidly, and the honest conversation about what IVF can and cannot accomplish during this phase is one that many clinics avoid because it's uncomfortable. This guide aims to give you the clear-eyed assessment you deserve.

Perimenopause & Fertility

Perimenopause is characterized by fluctuating hormone levels, increasingly irregular cycles, and progressive depletion of the ovarian follicle reserve. FSH levels rise (though they fluctuate), AMH declines, antral follicle counts drop, and the quality of remaining eggs deteriorates — with higher rates of chromosomal abnormalities (aneuploidy) in each egg.

The fertility impact is driven primarily by egg quality, not quantity. A perimenopausal patient may still produce follicles and eggs, but the percentage of those eggs that are chromosomally normal drops significantly with each year after 40 — from roughly 50% at age 40 to under 20% at age 43–44.

Own-Egg IVF: The Numbers

This is the section that requires unflinching honesty. National IVF databases (SART in the US, HFEA in the UK) consistently show that own-egg IVF success rates decline sharply after 40 and become very low after 42–43:

These are population averages from large databases. Individual outcomes vary — some 43-year-olds have better ovarian reserve than some 38-year-olds — but the trend is biologically driven and doesn't reverse. Multiple cycles improve cumulative odds, but the per-cycle probability remains low.

PGT-A (preimplantation genetic testing) becomes increasingly valuable in this age group — not because it improves egg quality, but because it prevents the transfer of aneuploid embryos that would result in failed implantation or miscarriage. The trade-off is that PGT-A may result in no euploid embryos available for transfer, which is emotionally difficult but spares the physical and emotional cost of a doomed transfer.

Donor Eggs: The Realistic Path

For perimenopausal patients, donor-egg IVF offers the highest probability of a live birth. Success rates with donor eggs are determined by the donor's age and egg quality — not the recipient's ovarian status. Clinical pregnancy rates of 50–65% per transfer are typical regardless of the recipient's age, because the uterus maintains its ability to carry a pregnancy well beyond the age of ovarian decline.

The decision to move from own-egg to donor-egg IVF is one of the most emotionally complex transitions in fertility treatment. Genetic connection matters to many people, and the grief of releasing that possibility is real and valid. Working with a fertility counselor who specializes in third-party reproduction can help you process this transition at your own pace.

Signs It's Time to Transition

There's no universal rule for when to stop own-egg attempts, but these indicators suggest diminishing returns:

• Multiple cycles with fewer than 3 eggs retrieved despite maximal stimulation
• No euploid embryos after PGT-A across 2+ cycles
• AMH consistently below 0.3 ng/mL with AFC under 3
• FSH consistently above 15–20 IU/L
• Cancelled cycles due to poor response
• Emotional exhaustion outpacing the remaining probability of success

Setting a defined endpoint before beginning — "we'll try X own-egg cycles and then transition" — can provide structure and protect against the cycle of indefinite hope that delays the transition to a higher-probability path.

Making the Most of Limited Time

If you're pursuing own-egg IVF during perimenopause, time is the most constrained resource. Strategies to maximize your window include banking embryos across multiple cycles before transferring (to accumulate and test before committing), pursuing aggressive protocols (high-dose stimulation, DuoStim), considering natural or mini-IVF cycles (lower-dose approaches that may yield 1–2 high-quality eggs per cycle with lower medication burden), and PGT-A testing all embryos before transfer to avoid failed transfers and miscarriages from aneuploid embryos.

Perimenopausal IVF in Colombia

Colombia's fertility clinics offer both own-egg and donor-egg IVF for perimenopausal patients. The cost advantage is particularly relevant for this group — where multiple own-egg cycles may be needed before achieving a euploid embryo, or where the transition to donor eggs represents a second major financial commitment. Own-egg cycles at $3,500–$5,500 (vs. $15,000–$22,000 in the US) make multi-cycle banking financially feasible, and donor-egg cycles at $6,500–$9,500 (vs. $25,000–$40,000) provide an accessible transition path.

Colombian clinics typically do not impose rigid age cutoffs the way some US clinics do — most will treat patients up to age 50–55 for donor-egg cycles, with individual assessment. For own-egg cycles, clinics evaluate candidacy based on ovarian reserve markers rather than age alone.

Explore Our Colombia Medical Network